Jiangsu Kanion Pharmaceutical Co Ltd Cash Flow Quality Index
Jiangsu Kanion Pharmaceutical Co Ltd cash flow quality index. Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a Cash Flow Quality Index of 3.52x as of September 2025. Operating cash flow of CN¥201.83 Million exceeds net income of CN¥57.27 Million, indicating high earnings quality where cash backs reported profits. Explore 600557 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Jiangsu Kanion Pharmaceutical Co Ltd (2001–2024)
Cash flow quality index of Jiangsu Kanion Pharmaceutical Co Ltd from 2001 to 2024. Historical Cash Flow Quality Index for Jiangsu Kanion Pharmaceutical Co Ltd across 24 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 600557 net asset quality score to measure how much of total assets are equity-financed.
Jiangsu Kanion Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2001–2024)
Jiangsu Kanion Pharmaceutical Co Ltd cash flow quality index by year from 2001 to 2024. Year-by-year earnings quality comparison for Jiangsu Kanion Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 600557 operating cash flow.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.84x | CN¥702.49 Million | CN¥380.92 Million | ▲ +1.8% |
| 2023 | 1.81x | CN¥972.32 Million | CN¥536.73 Million | ▼ -21.0% |
| 2022 | 2.29x | CN¥995.94 Million | CN¥434.47 Million | ▼ -18.1% |
| 2021 | 2.80x | CN¥908.30 Million | CN¥324.35 Million | ▲ +9.5% |
| 2020 | 2.56x | CN¥701.10 Million | CN¥274.03 Million | ▲ +42.8% |
| 2019 | 1.79x | CN¥925.73 Million | CN¥516.51 Million | ▲ +23.2% |
| 2018 | 1.45x | CN¥636.39 Million | CN¥437.60 Million | ▲ +43.6% |
| 2017 | 1.01x | CN¥382.93 Million | CN¥378.18 Million | ▲ +27.4% |
| 2016 | 0.79x | CN¥299.02 Million | CN¥376.15 Million | ▼ -43.6% |
| 2015 | 1.41x | CN¥514.80 Million | CN¥365.24 Million | ▲ +46.2% |
| 2014 | 0.96x | CN¥311.54 Million | CN¥323.11 Million | ▼ -25.3% |
| 2013 | 1.29x | CN¥388.11 Million | CN¥300.68 Million | ▲ +46.1% |
| 2012 | 0.88x | CN¥212.11 Million | CN¥240.14 Million | ▲ +85.6% |
| 2011 | 0.48x | CN¥90.19 Million | CN¥189.46 Million | ▼ -47.6% |
| 2010 | 0.91x | CN¥166.40 Million | CN¥183.21 Million | ▲ +766.2% |
| 2009 | -0.14x | CN¥-21.87 Million | CN¥160.40 Million | ▼ -133.4% |
| 2008 | 0.41x | CN¥58.39 Million | CN¥142.99 Million | ▼ -57.0% |
| 2007 | 0.95x | CN¥92.73 Million | CN¥97.57 Million | ▼ -43.1% |
| 2006 | 1.67x | CN¥108.98 Million | CN¥65.21 Million | ▼ -17.8% |
| 2005 | 2.03x | CN¥101.44 Million | CN¥49.89 Million | ▲ +346.9% |
| 2004 | 0.45x | CN¥21.68 Million | CN¥47.66 Million | ▼ -2.2% |
| 2003 | 0.47x | CN¥17.13 Million | CN¥36.81 Million | ▼ -12.7% |
| 2002 | 0.53x | CN¥11.15 Million | CN¥20.93 Million | ▼ -53.2% |
| 2001 | 1.14x | CN¥21.02 Million | CN¥18.45 Million | — |